SHE:002019

3 stories mentioning SHE:002019Updated just now

Every FINWIRES story that references SHE:002019, newest first.

Yifan Pharmaceutical Subsidiary Wins National Procurement Bid for Loquat Syrup

Yifan Pharmaceutical (SHE:002019) subsidiary Suzhou Yifan secured a winning bid for its Qiangli Pipalu (strong loquat syrup) in the national centralized procurement of Chinese patent medicines.The product, used for bronchitis-related cough, will be supplied under a procurement cycle running through Dec. 31, 2028, according to a Monday filing with the Shenzhen bourse.Shares of the pharmaceutical company climbed 1% in recent trade.

SHE:002019

Asia34d ago

Yifan Pharmaceutical Arm Gets China Nod for Anti-Itching Injection for Dialysis Patients

China's drug regulator granted Yifan Pharmaceutical (SHE:002019) subsidiary Hefei Yifan Biopharmaceutical marketing and production approval for its difenafine acetate injection.The drug helps treat moderate to severe pruritus or itching in hemodialysis patients, according to a Saturday filing with the Shenzhen bourse.

SHE:002019

Asia38d ago

Yifan Pharmaceutical Gets China Nod for Osteoporosis Biosimilar Trial

Yifan Pharmaceutical (SHE:002019) obtained Chinese regulatory approval to begin clinical trials for teriparatide injection.The drug, a biosimilar to Eli Lilly's Forteo, is indicated for treating osteoporosis in postmenopausal women at high fracture risk, according to a Thursday filing with the Shenzhen bourse.Shares of the pharmaceutical company closed 3% lower Thursday.

SHE:002019

Track with the FINWIRES app suite

FolioX

Track SHE:002019 in your portfolio

WheelAI

Analyze SHE:002019 options with the wheel strategy

StockInsider

See market sentiment on SHE:002019